| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Tech Ops And Admin | EVP &General Counsel
2 companies
Christian Waage serves as an EVP, Tech Ops And Admin at GOSS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 6 buys and 7 sells.
Historically, Christian Waage's trades have earned a strong insider score of 75/100 across 9 rated trades. Over a 12-month horizon, 88.9% of those trades were profitable, with an average 12-month return of +33.9%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2019 | GOSS Gossamer Bio, Inc. | EVP &General Counsel | Buy | 1,000 | $16.65 | $16,654.20 | +29.0% | |
| May 15, 2019 | HRTX Heron Therapeutics, Inc. /de/ | Director | Buy | 1,400 | $18.04 | $25,261.74 | New | |
| Feb 12, 2019 | GOSS Gossamer Bio, Inc. | EVP &General Counsel | Buy | 1,550 | $16.00 | $24,800.00 | +0.3% |